CBIZ (CBZ) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Apr, 2026Executive summary
Annual Meeting scheduled for May 14, 2026, to elect two directors, ratify KPMG LLP as auditor, and hold a say-on-pay vote.
Proxy materials distributed electronically and by mail, with voting available online, by phone, or mail.
Shareholders of record as of March 17, 2026, are eligible to vote; quorum requires a majority of outstanding shares.
Voting matters and shareholder proposals
Proposals include election of two directors (Marabito and Young), auditor ratification, and advisory approval of executive compensation.
Majority vote required for all proposals; abstentions count as votes against for auditor and compensation, but not for directors.
Shareholder proposals for the 2027 meeting must be submitted by December 3, 2026.
Board of directors and corporate governance
Board consists of nine members, divided into three classes; eight are independent under NYSE rules.
Chair is independent and separate from CEO; annual self-assessments conducted.
Three standing committees: Audit, Compensation and Human Capital, Nominating and Governance—all members independent.
Board and committees met regularly in 2025; all directors attended at least 75% of meetings.
Latest events from CBIZ
- Director elections, auditor ratification, and executive pay up for vote at annual meeting.CBZ
Proxy filing2 Apr 2026 - Revenue up 52% to $2.8B in 2025, with 2026 targeting 2–5% growth and higher free cash flow.CBZ
Q4 202525 Feb 2026 - Q2 revenue up 5.4%; $2.3B Marcum deal to close Q4, creating a top-7 U.S. accounting provider.CBZ
Q2 20242 Feb 2026 - Balanced organic and acquisition-driven growth, high retention, and margin expansion drive outperformance.CBZ
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 adjusted EPS up 27.3% and Marcum acquisition completed, boosting scale and leverage.CBZ
Q3 202418 Jan 2026 - Acquisition of Marcum creates a top-7 firm, boosting scale, recurring revenue, and growth prospects.CBZ
Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - Q1 2025 revenue up 69.5% to $838M, adjusted EBITDA doubled, Marcum integration on track.CBZ
Q1 202525 Dec 2025 - 2025 guidance: $2.90–$2.95B revenue, $3.60–$3.65 adjusted EPS, $450M–$456M EBITDA.CBZ
Q4 202421 Dec 2025 - Shareholders to vote on $2.3B Marcum acquisition, with major stock issuance and board changes.CBZ
Proxy Filing1 Dec 2025